Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Cataract > Rapid preoperative glycemic control tied to higher complication rates after cataract surgery
  • Cataract

Rapid preoperative glycemic control tied to higher complication rates after cataract surgery

Ophthalmology 360

Key Takeaways

  1. Rapid preoperative glycemic control was associated with higher rates of postoperative complications, particularly macular edema and vitreous hemorrhage.
  2. Rapid glycemic correction and more advanced diabetic retinopathy were the main risk factors for complications.
  3. Visual acuity improved significantly after surgery, and timely intervention for diabetic retinopathy was linked to fewer severe complications.

Rapid preoperative glycemic control in patients with type 2 diabetes and elevated HbA1c levels was associated with higher rates of postoperative complications following cataract surgery, according to a retrospective cohort study.

Researchers reviewed medical records from 152 patients (222 eyes) with HbA1c greater than 9.0% who underwent rapid glycemic control over an average of about 17 days, and 111 patients (162 eyes) with HbA1c below 7.0%. Outcomes were assessed over a 6-month postoperative period.

Macular edema and vitreous hemorrhage occurred in 11.7% of eyes in the rapid control group and 4.9% in the basic control group (P = 0.021). Rapid glycemic correction (P < 0.001) and moderate to severe non-proliferative diabetic retinopathy were identified as key risk factors for postoperative complications.

Among patients in the rapid control group who received timely intervention for diabetic retinopathy, only 3.8% developed severe complications (P = 0.019). No cases of endophthalmitis, hyphema, or incision leakage were reported in this group.

Despite the increased complication risk, visual outcomes improved significantly. Mean best-corrected visual acuity in the rapid control group improved from 1.26 ± 0.74 logMAR preoperatively to 0.30 ± 0.32 logMAR at final follow-up (P < 0.0001).

Reference

Wang Y, Wu X, Liu X, et al. Surgical Outcomes of Cataract Surgery Following Rapid Glycemic Control During Preoperative Period. Clin Ophthalmol. 2026;20:561071. doi: 10.2147/OPTH.S561071. PMID: 41847524; PMCID: PMC12990226.

Share

Related Content

  • Trending Topics

AI-based diagnostics show promise for early ocular disease detection

  • Trending Topics

Study explores retinal findings in pregnant women with COVID-19

  • Cataract

IOL exchange shows highest success for dissatisfaction after presbyopia-correcting lens surgery

  • Cataract

Head-to-head study highlights differences between EDoF intraocular lenses

  • Conference Roundup

EVO ICL surgery now FDA-approved for older patients

  • Trending Topics

Spotlight on VYZULTA®

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon